References
- MckeithIGGalaskoDKosakaKConsensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International workshopNeurology1996475111311248909416
- AarslandDRongveANoreSPFrequency and case identification of dementia with Lewy bodies using the revised consensus criteriaDement Geriatr Cogn Disord200826544545218974647
- MoriEIkedaMKosakaKSInvestigators D-DLBS, Donepezil-DLB Study InvestigatorsDonepezil for dementia with Lewy bodies: a randomized, placebo-controlled trialAnn Neurol2012721415222829268
- KohenILesterPELamSAntipsychotic treatments for the elderly: efficacy and safety of aripiprazoleNeuropsychiatr Dis Treat20106475820361061
- DeleonAPatelNCCrismonMLAripiprazole: a comprehensive review of its pharmacology, clinical efficacy, and tolerabilityClin Ther200426564966615220010
- BurrisKDMolskiTFXuCAripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptorsJ Pharmacol Exp Ther2002302138138912065741
- MintzerJETuneLEBrederCDAripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed dosesAm J Geriatr Psychiatry2007151191893117974864
- LeeHCooneyJMLawlorBAThe use of risperidone, an atypical neuroleptic, in Lewy body diseaseInt J Geriatr Psychiatry199495415417
- AllenRLWalkerZD’AthPJKatonaCLRisperidone for psychotic and behavioural symptoms in Lewy body dementiaLancet199534689681857541499
- TakahashiHYoshidaKSugitaTHiguchiHShimizuTQuetiapine treatment of psychotic symptoms and aggressive behavior in patients with dementia with Lewy bodies: a case seriesProg Neuropsychopharmacol Biol Psychiatry200327354955312691793
- LanctôtKLHerrmannNDonepezil for behavioural disorders associated with Lewy bodies: a case seriesInt J Geriatr Psychiatry200015433834510767734
- MarderSRMcquadeRDStockEAripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trialsSchizophr Res2003612–312313612729864
- FernandezHHTrieschmannMEFriedmanJHAripiprazole for drug-induced psychosis in Parkinson disease: preliminary experienceClin Neuropharmacol20042714515090928
- De DeynPJesteDVSwaninkRAripiprazole for the treatment of psychosis in patients with Alzheimer’s disease: a randomized, placebo-controlled studyJ Clin Psychopharmacol200525546346716160622
- StreimJEPorsteinssonAPBrederCDA randomized, double-blind, placebo-controlled study of aripiprazole for the treatment of psychosis in nursing home patients with Alzheimer diseaseAm J Geriatr Psychiatry200816753755018591574
- MucciAPiegariGGalderisiSCognitive-enhancing effects of aripiprazole: a case reportClin Pract Epidemiol Ment Health2008412418959801
- KimSWShinISKimJMEffectiveness of switching to aripiprazole from atypical antipsychotics in patients with schizophreniaClin Neuropharmacol200932524324919620849
- RiedelMSpellmannISchennach-WolffREffect of aripiprazole on cognition in the treatment of patients with schizophreniaPharmacopsychiatry2010432505720336597
- SuzukiHGenKInoueYAn unblinded comparison of the clinical and cognitive effects of switching from first-generation antipsychotics to aripiprazole, perospirone or olanzapine in patients with chronic schizophreniaProg Neuropsychopharmacol Biol Psychiatry201135116116821047544